FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Sertraline Hydrochloride Tablets
Status: Currently in Shortage
»Date first posted: 05/29/2020
»Therapeutic Categories: Pediatric; Psychiatry

Expand all

Accord Healthcare Inc. (Revised 08/31/2020)

Company Contact Information:
866-941-7875, option 2

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
25 mg, 30 count (NDC 16729-215-10) Available
25 mg, 90 count (NDC 16729-215-15) Available
25 mg, 500 count (NDC 16729-215-16) Limited supply/out of stock. Cannot supoort monthly demand. Estimated shortage duration: 90 days. API delivery has been delayed due to the impacts caused by COVID-19. Manufacturing and Packaging utilization and allocation process remains active. Other
50 mg, 90 count (NDC 16729-216-15) Limited supply/out of stock. Cannot supoort monthly demand. Estimated shortage duration: 90 days. API delivery has been delayed due to the impacts caused by COVID-19. Manufacturing and Packaging utilization and allocation process remains active. Other
50 mg, 500 count (NDC 16729-216-16) Limited supply / out of stock. Cannot support monthly demand. Estimated shortage duration: 90 days. API delivery has been delayed due to the impacts caused by COVID-19. Manufacturing and Packaging utilization and allocation process remains active. Other
100 mg, 90 count (NDC 16729-217-15) Limited supply / out of stock. Cannot support monthly demand. Estimated shortage duration: 90 days. API delivery has been delayed due to the impacts caused by COVID-19. Manufacturing and Packaging utilization and allocation process remains active. Other
100 mg, 500 count (NDC 16729-217-16) Limited supply / out of stock. Cannot support monthly demand. Estimated shortage duration: 90 days. API delivery has been delayed due to the impacts caused by COVID-19. Manufacturing and Packaging utilization and allocation process remains active. Other

Aurobindo Pharma (Reverified 08/31/2020)

Company Contact Information:
866-850-2876

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
25 mg, 30 count (NDC 65862-011-30) Available Sufficient quantities available for current and future demand increases.
25 mg, 100 count (NDC 65862-011-01) Available Sufficient quantities available for current and future demand increases.
25 mg, 500 count (NDC 65862-011-05) Available Sufficient quantities available for current and future demand increases.
50 mg, 30 count (NDC 65862-012-30) Available Sufficient quantities available for current and future demand increases.
50 mg, 100 count (NDC 65862-012-01) Available Sufficient quantities available for current and future demand increases.
50 mg, 500 count (NDC 65862-012-05) Available Sufficient quantities available for current and future demand increases.
100 mg, 30 count (NDC 65862-013-30) Available Sufficient quantities available for current and future demand increases.
100 mg, 100 count (NDC 65862-013-01) Available Sufficient quantities available for current and future demand increases.
100 mg, 500 count (NDC 65862-013-05) Available Sufficient quantities available for current and future demand increases.
25 mg, 30 count (NDC 16714-611-01) Available Northstar Rx label. Product distributed by: McKesson (972-446-4800)
25 mg, 100 count (NDC 16714-611-04) Available Northstar Rx label. Product distributed by: McKesson (972-446-4800)
25 mg, 500 count (NDC 16714-611-05) Available Northstar Rx label. Product distributed by: McKesson (972-446-4800)
25 mg, 1000 count (NDC 16714-611-06) Available Northstar Rx label. Product distributed by: McKesson (972-446-4800)
50 mg, 30 count (NDC 16714-612-01) Available Northstar Rx label. Product distributed by: McKesson (972-446-4800)
50 mg, 100 count (NDC 16714-612-04) Available Northstar Rx label. Product distributed by: McKesson (972-446-4800)
50 mg, 500 count (NDC 16714-612-05) Available Northstar Rx label. Product distributed by: McKesson (972-446-4800)
50 mg, 1000 count (NDC 16714-612-06) Available Northstar Rx label. Product distributed by: McKesson (972-446-4800)
100 mg, 30 count (NDC 16714-613-01) Available Northstar Rx label. Product distributed by: McKesson (972-446-4800)
100 mg, 100 count (NDC 16714-613-04) Available Northstar Rx label. Product distributed by: McKesson (972-446-4800)
100 mg, 500 count (NDC 16714-613-05) Available Northstar Rx label. Product distributed by: McKesson (972-446-4800)
100 mg, 1000 count (NDC 16714-613-06) Available Northstar Rx label. Product distributed by: McKesson (972-446-4800)

InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd) (Revised 09/02/2020)

Company Contact Information:
866-604-3268

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
25 mg, 30 count (NDC 69097-833-02) Available Distributed by Cipla USA Inc.
25 mg, 90 count (NDC 69097-833-05) Available Distributed by Cipla USA Inc.
25 mg, 500 count (NDC 69097-833-12) Available Distributed by Cipla USA Inc.
50 mg, 30 count (NDC 69097-834-02) Available Distributed by Cipla USA Inc.
50 mg, 500 count (NDC 69097-834-12) Available Distributed by Cipla USA Inc.
100 mg, 30 count (NDC 69097-835-02) Available Distributed by Cipla USA Inc.
100 mg, 500 count (NDC 69097-835-12) Available Distributed by Cipla USA Inc.
25 mg, 30 count (NDC 76282-212-30) Available Distributed by Exellan
25 mg, 60 count (NDC 76282-212-60) Available Distributed by Exellan
25 mg, 90 count (NDC 76282-212-90) Available Distributed by Exellan
25 mg, 100 count (NDC 76282-212-01) Available Distributed by Exellan
25 mg, 180 count (NDC 76282-212-18) Available Distributed by Exellan
25 mg, 500 count (NDC 76282-212-05) Available Distributed by Exellan
50 mg, 30 count (NDC 76282-213-30) Available Distributed by Exellan
50 mg, 60 count (NDC 76282-213-60) Available Distributed by Exellan
50 mg, 90 count (NDC 76282-213-90) Available Distributed by Exellan
50 mg, 100 count (NDC 76282-213-01) Available Distributed by Exellan
50 mg, 180 count (NDC 76282-213-18) Available Distributed by Exellan
50 mg, 500 count (NDC 76282-213-05) Available Distributed by Exellan
100 mg, 30 count (NDC 76282-214-30) Available Distributed by Exellan
100 mg, 60 count (NDC 76282-214-60) Available Distributed by Exellan
100 mg, 90 count (NDC 76282-214-90) Available Distributed by Exellan
100 mg, 100 count (NDC 76282-214-01) Available Distributed by Exellan
100 mg, 180 count (NDC 76282-214-18) Available Distributed by Exellan
100 mg, 500 count (NDC 76282-214-05) Available Distributed by Exellan

Lupin (Reverified 09/01/2020)

Company Contact Information:
866-587-4617

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
25 mg, 30 count (NDC 68180-351-06) Continuous production but due to increase in demand and API shortage, product is/will be on/off backorder for few months. Shortage of an active ingredient.
25 mg, 90 count (NDC 68180-351-09) Continuous production but due to increase in demand and API shortage, product is/will be on/off backorder for few months. Shortage of an active ingredient.
25 mg, 1000 count (NDC 68180-351-03) Continuous production but due to increase in demand and API shortage, product is/will be on/off backorder for few months. Shortage of an active ingredient.
50 mg, 30 count (NDC 68180-352-06) Continuous production but due to increase in demand and API shortage, product is/will be on/off backorder for few months. Shortage of an active ingredient.
50 mg, 90 count (NDC 68180-352-09) Continuous production but due to increase in demand and API shortage, product is/will be on/off backorder for few months. Shortage of an active ingredient.
50 mg, 500 count (NDC 68180-352-02) Continuous production but due to increase in demand and API shortage, product is/will be on/off backorder for few months. Shortage of an active ingredient.
50 mg, 5000 count (NDC 68180-352-05) Continuous production but due to increase in demand and API shortage, product is/will be on/off backorder for few months. Shortage of an active ingredient.
100 mg, 30 count (NDC 68180-353-06) Continuous production but due to increase in demand and API shortage, product is/will be on/off backorder for few months. Shortage of an active ingredient.
100 mg, 90 count (NDC 68180-353-09) Continuous production but due to increase in demand and API shortage, product is/will be on/off backorder for few months. Shortage of an active ingredient.
100 mg, 500 count (NDC 68180-353-02) Continuous production but due to increase in demand and API shortage, product is/will be on/off backorder for few months. Shortage of an active ingredient.
100 mg, 5000 count (NDC 68180-353-05) Continuous production but due to increase in demand and API shortage, product is/will be on/off backorder for few months. Shortage of an active ingredient.

Pfizer Pharmaceuticals (Reverified 11/20/2020)

Company Contact Information:
800-533-4535

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Zoloft 25 mg; Bottle of 30 tablets (NDC 0049-4960-30) Available Other
Zoloft 50 mg; Bottle of 30 tablets (NDC 0049-4900-30) Available Other
Zoloft 50 mg; Blister of 10 tablets (NDC 0049-4900-41) Available Other
Zoloft 100 mg; Bottle of 30 tablets (NDC 0049-4910-30) Available Other
Zoloft 100 mg; Blister of 10 tablets (NDC 0049-4910-41) Available Other
25 mg; Bottle of 30 tablets (NDC 59762-6347-1) Available Other
50 mg; Bottle of 30 tablets (NDC 59762-6443-1) Available Other
50 mg; Bottle of 100 tablets (NDC 59762-6443-2) Next Delivery and Estimated Recovery: March 2022 Demand increase for the drug
50 mg; Bottle of 500 tablets (NDC 59762-6443-3) Next Delivery and Estimated Recovery: March 2022 Other
100 mg; Bottle of 30 tablets (NDC 59762-5160-1) Available Other
100 mg; Bottle of 100 tablets (NDC 59762-5160-2) Available Demand Increase for the drug
100 mg; Bottle of 500 tablets (NDC 59762-5160-3) Next Delivery and Estimated Recovery: March 2022 Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English